Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054)
Cat.#: ACPP-1054
Specifications
Despition Recombinant Human Neuroglycan C Protein (6×His Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence CSPG5 (Val31-Gln420) + 6×His Tag Molecular Weight 41.9 kDa without signal peptide Purity > 85% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal 6×His Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1097 Synthetic Nanodisc Human ENTPD2 Protein (AC1097) 10 µg inquiry ACPP-1628 Human LIF Protein, GST (AC1628) 2 µg inquiry ACPP-1144 Synthetic Nanodisc Human GIPR Protein (AC1144) 10 µg inquiry ACPP-1651 Human AIDA Protein (AC1651) 2 µg inquiry ACPP-1619 Mouse CRYAB Protein (AC1619) 5 µg inquiry ACPP-1379 Human OLFM1 Protein (AC1379) 2 µg inquiry ACPP-1318 Orexin A Blocking Peptide (AC1318) 250 µg inquiry ACPP-1449 Human IL 6 Protein, CHO (AC1449) 5 µg inquiry ACPP-1066 Recombinant Human FGF2 Protein (Fc Tag) (AC1066) 50 µg inquiry ACPP-1008 Recombinant Human Siglec 7 Protein (6×His Tag) (AC1008) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket